Budesonide Inhalation Suspension
Product Images NDC 60687-524
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 60687-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: A 12-week Trial In Pediatric Patients Not On Inhaled Corticosteroid Therapy Prior To Study Entry. (Figure 1)
Figure 2: A 12-week Trial In Pediatric Patients Previously Maintained On Inhaled Corticosteroid Therapy Prior To Study Entry. (Figure 2)
Figure 3: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. (Figure 3)
Lupin Logo (Lupin Logo)
Figure 1 (Ifu Figure 2)
Figure 2 (Ifu Figure 3)
Figure 3 (Ifu Figure 4)
0.5 mg_2 mL Budesonide Inhalation Suspension Ampules Carton 30ud (Carton)
0.5 mg/2 mL Budesonide Inhalation Suspension Pouch (Foil)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.